Literature DB >> 24889387

Accuracy of visual inspection with acetic acid to detect cervical cancer precursors among HIV-infected women in Kenya.

Megan J Huchko1, Jennifer Sneden, George Sawaya, Karen Smith-McCune, May Maloba, Naila Abdulrahim, Elizabeth A Bukusi, Craig R Cohen.   

Abstract

Visual inspection with acetic acid (VIA) is becoming a more widely recommended and implemented screening tool for cervical cancer prevention programs in low-resource settings. Many of these settings have a high prevalence of HIV-infected women. We carried out a cross-sectional validation study to define the sensitivity, specificity and predictive values of VIA among HIV-infected women. Women enrolled in HIV care at the Family AIDS Care and Education Services clinic in Kisumu, Kenya, were recruited for participation. All participants underwent VIA followed by colposcopy performed by a second blinded clinician. At colposcopy, lesions suspicious for cervical intraepithelial neoplasia 2 or greater (CIN2+) were biopsied. Disease status was determined by final histopathologic diagnosis in women who underwent biopsies. A satisfactory colposcopy with no lesions was considered a negative result. From October 2010 to June 2012, 1,432 women underwent VIA and colposcopy. A total of 514 (35.7%) women had a positive VIA, and 179 (12.2%) had CIN2+ confirmed by colposcopically directed biopsy. Sensitivity, specificity, positive and negative predictive values of VIA for CIN2+ were 86.6, 71.6, 30.3 and 97.4%, respectively. Specificity, but not sensitivity, increased with older age. Among older women, sensitivity was affected by CD4+ count and use of antiretroviral therapy. Although they are impacted by age and immune status, test characteristics for VIA among HIV-infected women are similar to what has been reported for general populations. Recommendations to use VIA as a screening tool should not vary by HIV status.
© 2014 UICC.

Entities:  

Keywords:  HIV infection; Kenya; cervical cancer screening; visual inspection with acetic acid

Mesh:

Substances:

Year:  2014        PMID: 24889387      PMCID: PMC4214890          DOI: 10.1002/ijc.28996

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  37 in total

1.  Comparison of conventional cervical cytology versus visual inspection with acetic acid among human immunodeficiency virus-infected women in Western Kenya.

Authors:  Hillary Mabeya; Kareem Khozaim; Tao Liu; Omenge Orango; David Chumba; Latha Pisharodi; Jane Carter; Susan Cu-Uvin
Journal:  J Low Genit Tract Dis       Date:  2012-04       Impact factor: 1.925

2.  Utility of random cervical biopsy and endocervical curettage in a low-risk population.

Authors:  Robert G Pretorius; Jerome L Belinson; Faramarz Azizi; Patricia C Peterson; Suzanne Belinson
Journal:  J Low Genit Tract Dis       Date:  2012-10       Impact factor: 1.925

3.  Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial.

Authors:  Rengaswamy Sankaranarayanan; Pulikkottil Okkuru Esmy; Rajamanickam Rajkumar; Richard Muwonge; Rajaraman Swaminathan; Sivanandam Shanthakumari; Jean-Marie Fayette; Jacob Cherian
Journal:  Lancet       Date:  2007-08-04       Impact factor: 79.321

4.  Meta-analysis of the effectiveness of cryotherapy in the treatment of cervical intraepithelial neoplasia.

Authors:  Catherine Sauvaget; Richard Muwonge; Rengaswamy Sankaranarayanan
Journal:  Int J Gynaecol Obstet       Date:  2012-12-22       Impact factor: 3.561

5.  Comparison of pap smear, visual inspection with acetic acid, human papillomavirus DNA-PCR testing and cervicography.

Authors:  H De Vuyst; P Claeys; S Njiru; L Muchiri; S Steyaert; P De Sutter; E Van Marck; J Bwayo; M Temmerman
Journal:  Int J Gynaecol Obstet       Date:  2005-05       Impact factor: 3.561

6.  Evaluation of alternative methods of cervical cancer screening for resource-poor settings.

Authors:  L Denny; L Kuhn; A Pollack; H Wainwright; T C Wright
Journal:  Cancer       Date:  2000-08-15       Impact factor: 6.860

7.  Comparing Visual Inspection with Acetic Acid to Cytology in Detection of Precancerous Lesions of the Cervix in HIV-Infected Cambodian Women.

Authors:  Kruy Lim; Autumn Davidson; Joseph Harwell; Sovannara Thay; Lori A Boardman; Edward Feller; Susan Cu-Uvin
Journal:  J Int Assoc Physicians AIDS Care (Chic)       Date:  2011-03-23

8.  Cervical intraepithelial neoplasia grade 2 or worse in human immunodeficiency virus-infected women with mildly abnormal cervical cytology.

Authors:  Lori A Boardman; Kristen Cotter; Christina Raker; Susan Cu-Uvin
Journal:  Obstet Gynecol       Date:  2008-08       Impact factor: 7.661

9.  Comparison of HPV DNA testing in cervical exfoliated cells and tissue biopsies among HIV-positive women in Kenya.

Authors:  Hugo De Vuyst; Michael H Chung; Iacopo Baussano; Nelly R Mugo; Vanessa Tenet; Folkert J van Kemenade; Farzana S Rana; Samah R Sakr; Chris J L M Meijer; Peter J F Snijders; Silvia Franceschi
Journal:  Int J Cancer       Date:  2013-03-16       Impact factor: 7.396

10.  Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears. New York Cervical Disease Study.

Authors:  T C Wright; T V Ellerbrock; M A Chiasson; N Van Devanter; X W Sun
Journal:  Obstet Gynecol       Date:  1994-10       Impact factor: 7.661

View more
  15 in total

1.  Noncommunicable diseases among HIV-infected persons in low-income and middle-income countries: a systematic review and meta-analysis.

Authors:  Pragna Patel; Charles E Rose; Pamela Y Collins; Bernardo Nuche-Berenguer; Vikrant V Sahasrabuddhe; Emmanuel Peprah; Susan Vorkoper; Sonak D Pastakia; Dianne Rausch; Naomi S Levitt
Journal:  AIDS       Date:  2018-07-01       Impact factor: 4.177

2.  Novel concepts in cervical cancer screening: a comparison of VIA, HPV DNA test and p16INK4a/Ki-67 dual stain cytology in Western Kenya.

Authors:  Elkanah Omenge Orang'o; Edwin Were; Oliver Rode; Kapten Muthoka; Michael Byczkowski; Heike Sartor; Davy Vanden Broeck; Dietmar Schmidt; Miriam Reuschenbach; Magnus von Knebel Doeberitz; Hermann Bussmann
Journal:  Infect Agent Cancer       Date:  2020-10-02       Impact factor: 2.965

Review 3.  Cancer prevention in HIV-infected populations.

Authors:  Priscila H Goncalves; Jairo M Montezuma-Rusca; Robert Yarchoan; Thomas S Uldrick
Journal:  Semin Oncol       Date:  2015-09-08       Impact factor: 4.929

Review 4.  The East Africa Consortium for human papillomavirus and cervical cancer in women living with HIV/AIDS.

Authors:  Y Tong; E Orang'o; M Nakalembe; P Tonui; P Itsura; K Muthoka; M Titus; S Kiptoo; A Mwangi; J Ong'echa; R Tonui; B Odongo; C Mpamani; B Rosen; A Moormann; S Cu-Uvin; J A Bailey; C I Oduor; A Ermel; C Yiannoutsos; B Musick; E Sang; A Ngeresa; G Banturaki; A Kiragga; J Zhang; Y Song; S Chintala; R Katzenellenbogen; P Loehrer; D R Brown
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

Review 5.  A review of screening strategies for cervical cancer in human immunodeficiency virus-positive women in sub-Saharan Africa.

Authors:  Manuela Viviano; Pierre DeBeaudrap; Pierre-Marie Tebeu; Jovanny T Fouogue; Pierre Vassilakos; Patrick Petignat
Journal:  Int J Womens Health       Date:  2017-02-02

Review 6.  Associations between highly active antiretroviral therapy and the presence of HPV, premalignant and malignant cervical lesions in sub-Saharan Africa, a systematic review: current evidence and directions for future research.

Authors:  Sonia Menon; Rodolfo Rossi; Natasha Zdraveska; Mbabazi Kariisa; Sushama D Acharya; Davy Vanden Broeck; Steven Callens
Journal:  BMJ Open       Date:  2017-08-04       Impact factor: 2.692

7.  Acceptability and implementation challenges of smartphone-based training of community health nurses for visual inspection with acetic acid in Ghana: mHealth and cervical cancer screening.

Authors:  Ramin Asgary; Helen Cole; Philip Adongo; Ada Nwameme; Ernest Maya; Amanda Adu-Amankwah; Hannah Barnett; Richard Adanu
Journal:  BMJ Open       Date:  2019-07-16       Impact factor: 2.692

Review 8.  Cervical cancer prevention and treatment research in Africa: a systematic review from a public health perspective.

Authors:  Sarah Finocchario-Kessler; Catherine Wexler; May Maloba; Natabhona Mabachi; Florence Ndikum-Moffor; Elizabeth Bukusi
Journal:  BMC Womens Health       Date:  2016-06-04       Impact factor: 2.809

9.  Improving Access to Cancer Testing and Treatment in Kenya.

Authors:  Louise K Makau-Barasa; Sandra B Greene; Nicholas A Othieno-Abinya; Stephanie Wheeler; Asheley Skinner; Antonia V Bennett
Journal:  J Glob Oncol       Date:  2017-08-04

10.  Evaluating smartphone strategies for reliability, reproducibility, and quality of VIA for cervical cancer screening in the Shiselweni region of Eswatini: A cohort study.

Authors:  Ramin Asgary; Nelly Staderini; Simangele Mthethwa-Hleta; Paola Andrea Lopez Saavedra; Linda Garcia Abrego; Barbara Rusch; Tombo Marie Luce; Lorraine Rusike Pasipamire; Mgcineni Ndlangamandla; Elena Beideck; Bernhard Kerschberger
Journal:  PLoS Med       Date:  2020-11-19       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.